Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
10th Dec 202012:48 pmRNSFirst Interim Dividend
10th Dec 202012:30 pmRNSNet Asset Value(s)
10th Dec 202010:27 amRNSResult of AGM
9th Dec 202011:06 amRNSNet Asset Value(s)
8th Dec 202011:49 amRNSNet Asset Value(s)
7th Dec 202012:10 pmRNSGearing Disclosure
7th Dec 202011:09 amRNSNet Asset Value(s)
4th Dec 20202:31 pmRNSMonth End Net Asset Value(s)
4th Dec 202011:13 amRNSNet Asset Value(s)
3rd Dec 202012:39 pmRNSNet Asset Value(s)
2nd Dec 20203:47 pmRNSQuarterly disclosure
2nd Dec 20201:16 pmRNSNet Asset Value(s)
30th Nov 20202:58 pmRNSGearing disclosure
30th Nov 202011:54 amRNSNet Asset Value(s)
27th Nov 202012:47 pmRNSNet Asset Value(s)
26th Nov 202012:22 pmRNSNet Asset Value(s)
25th Nov 202012:53 pmRNSNet Asset Value(s)
24th Nov 202012:42 pmRNSNet Asset Value(s)
23rd Nov 20201:23 pmRNSGearing disclosure
23rd Nov 202012:50 pmRNSNet Asset Value(s)
20th Nov 202011:05 amRNSNet Asset Value(s)
19th Nov 202011:04 amRNSNet Asset Value(s)
18th Nov 20201:25 pmRNSNet Asset Value(s)
18th Nov 20209:45 amRNSNet Asset Value(s)
17th Nov 20207:00 amRNSDoc re. Annual Report
16th Nov 20201:29 pmRNSGearing disclosure
16th Nov 20201:14 pmRNSNet Asset Value(s)
13th Nov 202012:24 pmRNSNet Asset Value(s)
13th Nov 202012:00 pmRNSPortfolio disclosure
12th Nov 202010:56 amRNSNet Asset Value(s)
11th Nov 202011:13 amRNSNet Asset Value(s)
10th Nov 202011:19 amRNSNet Asset Value(s)
9th Nov 20202:33 pmRNSGearing disclosure
9th Nov 202012:12 pmRNSNet Asset Value(s)
6th Nov 202011:41 amRNSNet Asset Value(s)
5th Nov 20201:59 pmRNSMonth End Net Asset Value(s)
5th Nov 202011:14 amRNSNet Asset Value(s)
5th Nov 20207:00 amRNSAnnual Financial Report
4th Nov 202012:20 pmRNSNet Asset Value(s)
3rd Nov 20202:13 pmRNSNet Asset Value(s)
3rd Nov 20209:36 amRNSHolding(s) in Company
2nd Nov 20202:38 pmRNSGearing disclosure
30th Oct 202012:44 pmRNSNet Asset Value(s)
29th Oct 202012:40 pmRNSNet Asset Value(s)
28th Oct 202012:20 pmRNSNet Asset Value(s)
27th Oct 202011:02 amRNSNet Asset Value(s)
26th Oct 20203:27 pmRNSGearing Disclosure
26th Oct 202012:30 pmRNSNet Asset Value(s)
23rd Oct 20201:44 pmRNSNet Asset Value(s)
22nd Oct 202012:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.